Clinical Trials Sponsored by Sunesis Pharmaceuticals

Total 19549 results

Sunesis Pharmaceuticals

Terminated

Safety, PK, PD, and Antitumor Activity of Vecabrutinib (SNS-062) in B Lymphoid Cancers

Follicular Lymphoma | Waldenstrom Macroglobulinemia | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Mantle-Cell Lymphoma | Diffuse Large B Cell Lymphoma | Small Lymphocytic Lymphoma | Lymphoplasmacytoid Lymphoma

United States
Sunesis Pharmaceuticals

Completed

Safety and Tolerability Study of Voreloxin and Cytarabine Combination in Acute Myeloid Leukemia in Humans

Acute Myeloid Leukemia

United States
Sunesis Pharmaceuticals

Completed

Safety and Efficacy Clinical Study of SNS-595 in Patients With Platinum-Resistant Ovarian Cancer

Epithelial Ovarian Cancer

United States, Canada
Sunesis Pharmaceuticals

Completed

Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC

Carcinoma, Non-Small-Cell Lung

United States
Sunesis Pharmaceuticals

Completed

Study of Vosaroxin or Placebo in Combination With Cytarabine in Patients With First Relapsed or Refractory AML (VALOR)

Acute Myeloid Leukemia

United States, Canada, Spain, Belgium, Korea, Republic of, Australia, France, Germany, Poland, New Zealand, United Kingdom, Czechia, Austria, Hungary, Italy
Sunesis Pharmaceuticals

Completed

Study of Intravenously Administered SNS-032 in Patients With Advanced B-lymphoid Malignancies

Multiple Myeloma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | B-lymphoid Malignancies

United States
Sunesis Pharmaceuticals

Completed

Safety and Tolerability Study of SNS-314 for Advanced Solid Tumors

Advanced Solid Tumors

United States
Sunesis Pharmaceuticals

Completed

Safety Assessment of Two Schedules of Intravenous Infusions of SNS-595 for the Treatment of Hematologic Malignancies

Myelodysplastic Syndromes | Leukemia, Lymphocytic, Acute | Leukemia, Myeloid, Chronic | Leukemia, Nonlymphocytic, Acute

United States
Sunesis Pharmaceuticals

Completed

Safety Assessment of Weekly Intravenous Infusions of SNS-595 for the Treatment of Solid Tumors

Neoplasms

United States
Sunesis Pharmaceuticals

Completed

Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

Small Cell Lung Cancer | Carcinoma, Small Cell

United States, Canada
Sunesis Pharmaceuticals

Completed

Study of Voreloxin (Vosaroxin) in Older Patients With Untreated Acute Myeloid Leukemia

Acute Myeloid Leukemia | Myelodysplastic Syndromes | Leukemia | Acute Disease | Nonlymphocytic Leukemia

United States
Sunesis Pharmaceuticals

Completed

Safety Assessment of One-hour Infusions of SNS-032 for the Treatment of Select Advanced Solid Tumors

Tumors

United States
Sunesis Pharmaceuticals

Completed

Initial Safety Assessment of SNS-595 for the Treatment of Solid Tumors.

Neoplasms

United States
University of Ulm
Sunesis Pharmaceuticals

Completed

Study of Vosaroxin With Azacitidine in Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome With Excess Blasts-2

Acute Myeloid Leukemia | Myelodysplastic Syndrome With Excess Blasts-2 (MDS-EB-2)

Germany
M.D. Anderson Cancer Center
Sunesis Pharmaceuticals

Completed

Study of Vosaroxin and Decitabine in Older Patients With Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

Leukemia

United States
Washington University School of Medicine
Sunesis Pharmaceuticals

Active, not recruiting

Vosaroxin and Azacitidine in Treating Patients With Myelodysplastic Syndromes

Myelodysplastic Syndromes

United States
Weill Medical College of Cornell University
Sunesis Pharmaceuticals

Completed

Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy

Myelodysplastic Syndrome

United States
Genesis Foundation

Unknown

Determination of the Effectiveness of Oral Chlorine Dioxide in the Treatment of COVID 19

COVID-19

Colombia
Tissue Genesis

Active, not recruiting

Feasibility Study of the TGI Adipose-derived Stromal Cell (ASC)-Coated ePTFE Vascular Graft (TGI-PVG-IDE)

Lower Limb Ischemia

United States
Benesis Corporation

Completed

Efficacy and Safety Study of GB-0998 for Treatment of Generalized Myasthenia Gravis

Generalized Myasthenia Gravis

Japan
Tissue Genesis

Not yet recruiting

Evaluation of the Tissue Genesis Icellator Cell Isolation System to Treat Erectile Dysfunction

Erectile Dysfunction

United States
Tissue Genesis

Active, not recruiting

Evaluate the Use of Liposuction and Cell Separation Devices for Autologous Fat (Adipose) Derived Cells to Treat the Symptoms of Erectile Dysfunction

Erectile Dysfunction

United States
Genesis Limited

Terminated

A Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMS

Multiple Sclerosis, Relapsing-Remitting

Trinidad and Tobago
Benesis Corporation

Completed

Efficacy and Safety Study of GB-0998 for Treatment of Systemic Sclerosis

Scleroderma, Systemic

Japan
Nail Genesis LLC

Recruiting

Evaluation of the Effectiveness of Nail Genesis DLSO Product for Onychomycosis

Onychomycosis | Distal Lateral Subungual Onychomycosis

United States
Genesis Pharma S.A.

Completed

Real-world Evidence Prospective Study on the Effect of Nab-paclitaxel Treatment on the Clinical Outcomes and HRQoL in Patients With MBC in Greece (ABReast)

Metastatic Breast Cancer

Greece
Kinesis Health Associates

Completed

Transcutaneous Vagus Nerve Stimulation in Private Healthcare Center

Chronic Pain | Irritable Bowel Syndrome | Generalized Anxiety Disorder

Canada
RDO Pharm.
Beijing Pharbers Genesis Pharmaceutical Technology Co., Ltd.

Completed

A Study of 99mTc-3PRGD2 Injection in Lung Cancer Patient

Lung Cancer Metastatic

China
Genesis Medtech Corporation

Recruiting

Clinical Trial in China for Aortic Valve Stenosis

Diseases of Aortic Valve | Aortic Stenosis Disease

China
Genesis Medtech Corporation

Active, not recruiting

SOLUTION Trial in China

Peripheral Arterial Disease | Calcifications Vascular

China
Genesis Athens Clinic

Completed

Intrauterine Antibiotic Infusion in Treating Chronic Endometritis and Restoring Reproductive Dynamics

Chronic Endometritis

Greece
Genesis Pharma S.A.

Completed

A Retrospective Chart Review Study of the Outcomes of 2nd Line Therapy With LEn/Dex in Greek Patients With R/R Multiple MyEloma and the Treatment PatterNs Following Progressive Disease (LEGEND)

Relapsed/Refractory Multiple Myeloma

Greece
Genesis Research LLC

Recruiting

Investigator Initiated Trial to Further Evaluate the Safety and Efficacy of Trans-perineal Focal Laser Ablation of Localized Prostate Cancer Using High Frequency Micro-ultrasound Imaging

Prostate Cancer | Low-risk or Favorable Intermediate Risk Prostate Cancer Who Are on an Active Surveillance Regimen

United States
Genesis Medtech Corporation

Recruiting

Clinical Trial in China

Diseases of Aortic Valve | Aortic Regurgitation Disease

China
Genesis Medtech Corporation

Active, not recruiting

SOLSTICE Trial in China

Coronary Artery Disease | Calcifications Vascular

China
Genesis Pharma S.A.

Completed

Retrospective and Prospective Study of POmalidomide Plus LoW Dose Dexa Efficacy in RRMM Patients Under Real-Life Conditions (POWERFUL)

Relapse/Refractory Multiple Myeloma

Greece
Genesis Pharma S.A.

Completed

A Multicenter, Prospective, oBservational Study to assEss the Clinical activitY and Impact on symptOm Burden and patieNts' HRQoL of Treatment With trabecteDin in aSTS in a Real World Setting in Greece (beYOND-STS)

Advanced Soft Tissue Sarcoma

Greece
Genesis Health System

Unknown

The Use of Coconut Oil for the Prevention and Treatment of Diaper Dermatitis in the NICU Population

Dermatitis, Contact

United States
Genesis Pharma CNS & Specialty

Completed

Study to Assess Resource Utilization and Quality of Life of Patients With RRMS Treated With Tecfidera in Greece (FIDELITY)

RRMS

Greece
Genesis Pharma S.A.
Celgene

Completed

A Study of Treatment With APRemilast in Moderate psoriAsIS in Real Life clinicAL Practice (The 'APRAISAL' Study) (APRAISAL)

Moderate Plaque Psoriasis

Greece
Diakron Pharmaceuticals
Drug Research Unit Ghent, Ghent, Belgium; Kinesis Pharma B.V.

Terminated

A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.

Deep Vein Thrombosis Leg | Stroke (in Patients With Atrial Fibrillation)

Belgium
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment

Postmenopausal Women With Advanced Breast Cancer

Japan
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Extension Study of 1.0mg Dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Zhittya Genesis Medicine, Inc.

Not yet recruiting

Intranasal Human FGF-1 for Subjects With Parkinson's Disease

Parkinson Disease

Bahamas
Genesis Pharma CNS & Specialty

Completed

Fampridine in MS Patients: A Cognition, Fatigue, Depression and Quality of Life Analysis (FAMILY)

Multiple Sclerosis

Greece
Novartis Pharmaceuticals
Chugai Pharmaceutical

Completed

Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer

Postmenopausal Women With Advanced Breast Cancer

Japan
Genesis Pharma S.A.
Celgene; Amgen

Active, not recruiting

Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece (APROACH)

Psoriatic Arthritis

Greece
RDO Pharm.
Beijing Pharbers Genesis Pharmaceutical Technology Co., Ltd.; MedAlly Solutions...

Completed

A Study of 99mTc-3PRGD2 Injection in Healthy Volunteers

Healthy

China
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Renal Impairment
Novartis Pharmaceuticals
Pharmaceutical Research Associates

Withdrawn

Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Hepatic Impairment

Clinical Trials Sponsored by Sunesis Pharmaceuticals

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Nigeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations